Metallothionein and Superoxide Dismutase—Antioxidative Protein Status in Fullerene-Doxorubicin Delivery to MCF-7 Human Breast Cancer Cells

Doxorubicin (DOX) is one of the most frequently used anticancer drugs in breast cancer treatment. However, clinical applications of DOX are restricted, largely due to the fact that its action disturbs the pro/antioxidant balance in both cancerous and non-cancerous cells. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kepinska, Marta, Kizek, Rene, Milnerowicz, Halina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214080/
https://www.ncbi.nlm.nih.gov/pubmed/30347787
http://dx.doi.org/10.3390/ijms19103253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214080/
https://www.ncbi.nlm.nih.gov/pubmed/30347787
http://dx.doi.org/10.3390/ijms19103253

Ejemplares similares